Skip to main content

Anti-PD-1 monoclonal antibodies

Other names: anti-programmed cell death-1 (PD-1) monoclonal antibodies, immune checkpoint inhibitors, programmed death-ligand 1 (PD-L1) blocking antibodies

What are Anti-PD-1 monoclonal antibodies?

Programmed cell death protein 1 (PD-1) is an inhibitory receptor that is expressed on some tumor cells and causes down regulation of the immune system by reducing T-cell activity. Anti-PD-1 monoclonal antibodies block the PD-1 receptor so the T cells are no longer inhibited and therefore activates the immune response against the tumor.

List of Anti-PD-1 monoclonal antibodies:

View by  Brand | Generic
Drug Name Avg. Rating Reviews
Keytruda (Pro)
Generic name: pembrolizumab
3.6
149 reviews
Opdivo (Pro)
Generic name: nivolumab
4.5
60 reviews
Libtayo (Pro)
Generic name: cemiplimab
10
2 reviews
Tecentriq (Pro)
Generic name: atezolizumab
1 review
Jemperli (Pro)
Generic name: dostarlimab
No reviews
Imfinzi (Pro)
Generic name: durvalumab
No reviews
Bavencio (Pro)
Generic name: avelumab
No reviews
For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.